He's 61 years old, runs a solo practice he built from nothing in 1998, and has been saying "next year" for 4 years. Next year he'll start looking for a younger surgeon to buy in. Next year he'll have the conversation with his accountant. Next year he'll figure out what the practice is actually worth and what a transition could look like.

Last month his best technician of 11 years left for a hospital system down the street. Better benefits, more stability, and a pension. She told him she loved working there but she couldn't keep waiting to find out what was going to happen. His front desk coordinator has been asking quiet questions about her options. His patients are starting to notice that things feel different.

He's still good at what he does and the practice is still generating strong revenue. But the window he thought he had is getting shorter, and the buyer he's been picturing hasn't materialized, and somewhere in the back of his mind he knows the story he's been telling himself about how this ends may not be the one that actually plays out.

If you're a solo ophthalmologist over 55, you probably recognize some version of that story. The details are different but the structure is the same. You've been waiting for the right person to come along, and the right person hasn't shown up yet, and the practice keeps running, and you keep waiting.

Here's what you need to understand about why that buyer isn't coming and what that actually means for your timeline.

What Happened to the Traditional Buyer

20 years ago there was a natural order to how solo practices ended. A younger surgeon came in, worked alongside the founder for a few years, learned the patients, earned the referrals, and eventually bought in. The founder got fair value, the staff got continuity, the patients never knew anything had changed. It wasn't complicated, it just worked.

That path didn't disappear overnight. It eroded quietly and completely, one graduating class at a time, as the economics of becoming a physician changed and the alternatives got more attractive. The residents finishing fellowship today are carrying $200,000 or more in student loans before they've signed their first employment contract. The hospital down the street is offering a guaranteed salary, malpractice coverage, and no operational headaches. Private equity is offering a signing bonus at exactly the moment a young physician is most financially stretched. None of those people are looking to buy a solo practice. They're looking to survive the first 5 years without going broke, and the offers they're getting make that easier than ownership ever could.

So the pipeline dried up. The ophthalmologist who was supposed to want what you built is employed somewhere, probably on a non-compete, probably not thinking about ownership until it's too late to make a move without a fight. Only 8 new solo ophthalmology practices have opened in New York in the last 5 years, in a state with nearly 1,000 solo practitioners. The buyer you've been picturing exists. They're just increasingly rare, increasingly recruited before finishing fellowship, and increasingly locked into structures that make a move complicated by the time they're old enough to think clearly about what they actually want.

What Waiting Actually Costs

This is the part nobody talks about directly.

Every year you keep working past when you wanted to stop, you're subsidizing a transition plan that hasn't been built yet. That cost is invisible on a spreadsheet but it shows up everywhere else.

Your staff is aging alongside you. The people who have been with you for a decade built their professional identity around a practice that has a future. When that future becomes unclear, the best ones start quietly exploring their options. They don't announce it or cause drama. They just update their resumes and take the call when a hospital recruiter reaches out. When they leave, they take institutional knowledge with them that took years to build and can't be replaced quickly. The tech who knew every patient by name, who could run the diagnostic suite without being asked, who kept the schedule from falling apart on a busy Tuesday isn't easy to replace at any price.

Your referral network is also more fragile than it looks. The optometrists and PCPs who send patients to your practice do so because they trust you personally. That trust took years to earn and it's tied to your presence in the community. It doesn't automatically transfer to whoever comes next. A practice that transitions cleanly, with a successor physician in place, an introduction made to the referral network, and continuity of care maintained, can preserve most of that relationship equity. A practice that closes suddenly loses it entirely and whoever opens next has to rebuild from scratch.

Your patients feel it too, even if they don't say it. The subtle shift in energy when a practice is in transition, when staff are uncertain, when the future is unclear, is something patients pick up on before anyone articulates it. The ones who've been coming to you for 20 years are watching, and what they want to know is that someone they can trust is going to be there when you're not.

And then there's the practice itself. Equipment that needed replacing 2 years ago gets pushed another year. A lease renewal gets signed without really thinking about whether it fits a transition timeline. Small operational decisions that would look different if there was a clear endpoint keep accumulating. The practice that starts planning a transition today looks different from the one that starts planning 3 years from now, and not in a direction that improves value.

The Window Is Real

The next decade will see more solo ophthalmology practices change hands or close than in the entire previous generation. The retirement wave is already underway and the acceleration point is the next 3 to 5 years, as the densest cohort of solo practitioners moves through their late 50s and early 60s at the same time.

That wave creates 2 very different outcomes depending on timing.

The practices that transition early, while the founder still has energy, while the staff is still intact, while the referral network is still warm, while the revenue is still strong, have real options. They can be selective about who acquires them. They can negotiate from a position of strength. They can stay involved in a clinical capacity for as long as it makes sense. They can make sure their patients are taken care of and their staff keeps their jobs.

The practices that wait until the founder is already exhausted, until the best staff have left, until the referral network has started to thin, have significantly fewer options and significantly less leverage. Not because the practice isn't worth something, but because the transition has already started without a plan and the people executing it are operating under pressure instead of from strength.

The right time to start this conversation is before you feel like you have to.

What the Alternative Actually Looks Like

The model that works in this environment isn't the earn-in. It's an acquisition by an entity that already has the capital, the operational infrastructure, and the physician pipeline to execute a real transition.

The practice gets acquired at fair value and operations get stabilized under MSO management, which handles billing, staffing, marketing, compliance, and the operational weight the founder has been carrying alone for decades. A successor physician steps into something that already works rather than building from scratch. The founder can stay involved clinically for as long as it makes sense, on their own terms, rather than disappearing on a Friday and sending a letter.

The staff keeps their jobs, the patients keep their practice, and the referral relationships transfer to a physician who's been introduced properly and has time to earn trust before the handoff is complete.

That's not the exit you pictured 20 years ago when you signed your first lease. But it's an exit that works, and it's available now, while the conditions are still favorable.

The physicians who begin that conversation 2 to 3 years before they're ready to step back have the most leverage and the most options. The ones who wait until they're already done waiting tend to find that the market has moved past them.

We built Verdira to be the buyer that the traditional model stopped producing. If you've been thinking about what comes next and haven't found a real answer yet, we're worth a conversation.

This article is for general educational purposes and is not legal or financial advice.

Verdira is a healthcare acquisition platform focused on ophthalmology practices, built around physician ownership, transparent structure, and no volume quotas. If you're looking for a different model, or you know a colleague who is, contact us today.

Contact info@verdira.com | 307-381-3734 | verdira.com